The A.I. Daily
RSM roundtable: life sciences AI lacks strategy, early gains in productivity
An RSM US LLP roundtable found most life sciences organizations have AI usage policies but no full strategy tied to business goals; even among large, well-resourced firms only a minority have a defined roadmap. Early AI gains center on productivity, while real value comes from industry-specific use cases, and strong data management and governance are key to managing risk and scaling value.